- ￥2000 - 8000
- 湖北省武汉市
- Mouse Psmd2重组蛋白表达
- 2025年09月14日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 服务名称：
大肠杆菌系统重组蛋白表达
- 提供商：
普健生物（武汉）科技有限公司
Uniprot号：Q8VDM4
基因名：Psmd2
蛋白名：26S proteasome non-ATPase regulatory subunit 2
蛋白别名：
26S proteasome non-ATPase regulatory subunit 2, 26S proteasome regulatory subunit RPN1, 26S proteasome regulatory subunit S2, 26S proteasome subunit p97
服务内容：
| 服务项目 | 客户提供 | 服务内容 | 服务周期 | 交付内容 |
|---|---|---|---|---|
| 大肠杆菌系统 蛋白表达 |
基因序列 | 方案沟通 | 1天 | 方案报告 |
| 密码子优化和基因合成 | 5天 | 基因合成报告 | ||
| 表达纯化测试 | 3天 | 表达纯化测试报告 | ||
| 1L表达及纯化 | 3天 | 蛋白样品(3-5mg)及报告 | ||
| 放大发酵及纯化 | 7天 | 纯化的蛋白及报告 |
案例展示：
Psmd2相关研究文献：
1. PSMD2 overexpression as a biomarker for resistance and prognosis in renal cell carcinoma treated with immune checkpoint and tyrosine kinase inhibitors. [39222176]
2. PSMD2 promotes the progression of bladder cancer and is correlated with immune infiltration. [36505799]
3. PSMD2 contributes to the progression of esophageal squamous cell carcinoma by repressing autophagy. [36998052]
4. Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma. [35754829]
5. Identification of PSMD2 as a promising biomarker for pancreatic cancer patients based on comprehensive bioinformatics and in vitro studies. [39634424]
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验2. PSMD2 promotes the progression of bladder cancer and is correlated with immune infiltration. [36505799]
3. PSMD2 contributes to the progression of esophageal squamous cell carcinoma by repressing autophagy. [36998052]
4. Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma. [35754829]
5. Identification of PSMD2 as a promising biomarker for pancreatic cancer patients based on comprehensive bioinformatics and in vitro studies. [39634424]
技术资料暂无技术资料 索取技术资料
